Google DeepMind's AlphaFold 3 predicts interactions among proteins, DNA, RNA, ligands, and other biomolecules, while Isomorphic Labs introduced the Isomorphic Drug Design Engine (IsoDDE) for drug disc…
Nobel laureate John Jumper, co-creator of AlphaFold, left Google DeepMind for Anthropic to advance AI-for-science. Anthropic launched Claude Science, a research workbench, and opened grants for 50 pro…
A developer explains how the Transformer architecture, introduced by Google in 2017, replaced recurrent neural networks and LSTMs as the dominant paradigm in AI. The architecture processes all tokens …
The UN's first global AI science panel warned Wednesday that the window to govern artificial intelligence is closing, as the technology outpaces regulation. The preliminary report from the Independent…
Anthropic announced Claude Science, a new flagship product for scientific research, at an event for pharmaceutical executives and biotech founders on Tuesday. The product autonomously carries out work…
Anthropic launched an AI drug discovery program on May 5, 2025, offering free API credits to researchers in biology and life sciences. The company later launched Claude for Life Sciences and acquired …
Emily M. Bender, lead author of the influential 'Stochastic Parrots' paper, debunked common misconceptions about the term on its five-year anniversary. The paper, which argued that large language mode…
Despite advances in deep learning, models like AlphaFold that transform science remain rare because training on human text, which is downstream of hard-won knowledge, differs from training on frontier…
Google DeepMind CEO Demis Hassabis warned that artificial intelligence is overhyped in the short term but underappreciated in the long term, predicting a 'new golden era of discovery' in medicine, ene…
Australian tech entrepreneur Paul Conyngham used AI tools including ChatGPT and AlphaFold to design a personalized mRNA cancer vaccine for his dog Rosie, which shrank her tumors after conventional tre…
AI professor Carolyn Jean, who carries a high-risk cancer mutation, argues against rapid AI development despite potential benefits like curing cancer. She criticizes AI lab leaders' predictions of imm…
Anthropic published research showing frontier AI models achieved as low as 16.9% accuracy on identical viral sequence queries due to broken data infrastructure, not model limitations. A deterministic …
Nobel laureate John Jumper announced Friday he is leaving Google DeepMind for rival AI startup Anthropic after nearly nine years. Jumper, who shared the 2024 Nobel Prize in Chemistry for his work on A…
Nobel Prize-winning chemist John Jumper is leaving Google DeepMind for Anthropic, as reported by Reuters on June 19, 2026. Jumper, known for leading the AlphaFold project that predicted protein struct…
Nobel laureate John Jumper, who won the 2024 Nobel Prize in Chemistry for creating AlphaFold, is leaving Google DeepMind after nearly nine years to join Anthropic. The departure follows Gemini co-lead…
John Jumper, a Nobel Prize-winning scientist who co-led the development of AlphaFold at Google DeepMind, announced he is leaving the company to join Anthropic. The move highlights a broader trend of s…
John Jumper, the Google DeepMind vice president and Nobel Prize-winning scientist behind AlphaFold, is leaving the company to join Anthropic, the maker of the Claude AI assistant. His departure signal…
John Jumper, a Nobel Prize-winning chemist and computer scientist known for leading Google DeepMind's AlphaFold team, announced Friday he is leaving the company to join AI startup Anthropic. Jumper's …
John Jumper, former leader of the AlphaFold team at Google DeepMind, has left the company after nearly nine years to join Anthropic, an AI safety and research organization. Jumper expressed gratitude …
Google launched the Agent-to-Agent (A2A) protocol one year ago to enable collaborative AI agents. Now, the protocol is being used in life sciences through Foldrun, an agent that predicts protein struc…